Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ladies and Gentleman, Please!
One of the things that attracted me to NMUS was they had quiet Ihub board with posters who discussed facts and reality, Rather than mindless emotion driven pumping and screaming matches.
If someone doesn't see what you see, whether it's the potential of this company or risk factors, please do not let it get to the point where this board becomes a uninhabitable place. It would be sad!
Here are some facts that should clear up the last few dust ups:
According to their last Investors Presentation, fully diluted, there would be 45 million shares outstanding. Now, if Schneider Brothers convert 100% of their Series E shares, that would add roughly 65 million. So the current total is 100 million shares outstanding and a 30 million market cap. Someone please correct me if I am wrong. Look at the big boys market cap $GWPH and $ZYNE, or a peer like $IMLFF and their cash on hand and S/O.
They are NOT a strictly CBD bio-tech company. Both their Glaucoma and CINV candidates are THC derivatives, so it is not true they are strictly focused on CBD. In fact, I encourage anyone to go look at Dr. El Souhly's research to understand just how well he knows this plant.
NMUS has not conducted ANY Phase 1a-3 trials, this is correct. However, in addition to three of their candidates being pre-clinical with experiments on rabbits (who share a very similar genetic profile to humans), El Souhly has been researching this plant since 1975.
From what I read, the average FDA drug approval process (phase 1-3 and FDA verification/Phase 4) costs between 30-40 million start to finish, but it is hard to estimate the exact costs of a specific drug candidate. Vinpat, my good friend and the most knowledgeable NMUS follower, says their CINV candidate is likely to be much cheaper than the average drug.
I hope people no longer feel the need to pin each other down and convince them of their view point. Sell, hold or buy, who cares. Just make sure the discussion is a healthy one!
GLTFA
Well, it depends on what you think that twenty million will be used for and what are the motivations behind the group providing the financing?
Is the money going to only sustain the companies current operations, which means there will be further dilution down the road without any catalysts for SP appreciation? Or does the financing provide the opportunity to unlock value from the companies candidates and actually provide value for shareholders?
Is the group that provided the financing going to hold for long-term gains because they believe in the sector, IP and management? Or are they a group of poor morals and ethics, looking to dump their shares (which they paid a premium for compared to the then market SP) in the near future once they have realised/pump+dumped a 100-300% gain ($0.60-$1.20 SP)?
DYODD and GLTFA
Ya,
More of a black eye than a Red flag
Anything else Vinpat? They seem to be very conservative group of guys. 'Anglo Saxan' culture....into collecting fine art
Some Eyes Wide Shut stuff....
But at least not the Pump and Dump PIPE death spiral financing OTC used too
Due diligence on Schneider Brothers
What has everyone come up with? The only red flag I can find is their involvement with SGMZ (Sun Games) a few years ago. The CEO of SGMZ ended up getting arrested recently for defrauding investors.
From what I read, Schneider was supposed to get involved in 2014, got cold feet regarding their numbers/delayed SEC filings but still eventually did in 2015. People can read for themselves --- >
http://www.marketwired.com/press-release/sungame-corporation-secures-50m-usd-investment-commitment-from-schneider-brothers-otc%20pink-sgmz-2015135.htm
By the wording of it, I'm not even sure if the 50M ever happened.
Everything else comes up quite clean, and they seem to have offices all over the world. Since GWPH came out of London, maybe that is why they are interested in the cannibinoid space?
I have requests in to them to get a hold of their annual reports and credit reviews, but would like to here if anyone has unearthed anything.
GLTFA
Vinpat, you should be charging money.
For this type of precise analysis.
Tell me more about why you think GMP producers will be obsolete soon.
I am long on Cannimed Therapeutics but you have me shook now...
My good friend Vinpat
Enjoy the day Today
Not many on the OTC
But far from the last for NMUS
Don't feed the Trolls
Winners like NMUS focus on Winning
Losers focus on Winners
GLTFA
Justice Summit V - Mahmoud ElSohly
You don't think there will be a need/demand for GMP producers?
I am long on $CMED
It's like you said, the risk here is the ability to finance clinical trials (which still is big).
There is so much stigma still surrounding the plant, I can see it being very hard to get financing that doesn't result in serious dilution and the eventual erosion of shareholder value.
This sector is rife with Bottom of the Barrel people. I look at what is going on with other companies and Shake my head.
If we miss with NMUS, it won't be because We got left holding Bags of paper. It would be Because a geo-political event caused research in this sector to become unpalatable. Globally, it appears were headed in the opposite direction.
I agree with what you said about worse case scenario. If they can't set up reasonable financing for clinical trials or licensing deals in the next couple of years, they sell the IP to a Tier One player and those who bought the SP bottom make a bit of money. Our capital would of been better invested elsewhere, but we don't end up bust. I believe this because of the Quality people involved.
Uh huh
I'm not short VIN, I dont stock stocks. Shorting stocks is dangerous.
Since Core Capital is involved I'm sure things will go VERY smoothly.
Just like it did when Finore Mining acquired, or failed to acquire, Kushtown USA. Which probably never existed anyway....
Batell Invesments....Lexore Capital....seems like All Quality people involved
NOT
More like bottom of the barrel
DYODD and GLTFA
Cheers to my good friend Vinpat
A very Solid fellow
Vinpat will have much better answers than me but...
1) Given who is involved here, I would hope they find ways to raise that aren't as dilute as given in your example. Vinpat has always maintained NMUS is not interested in the retail investor. When Hollister was CEO, they seemed to be given how public he was. He LOVES talking about himself LOL.....Vinpat said they asked to be taken off Indexes of certain sketchy individuals like Brochstein. So I don't know, I think you ask a Very valid question here.
2) Here is a link to a presentation LOLHollister did, the former CEO
The Wuff of Weed has called a lot of things
WRONG
10 million CDN $.20 shares and 5 million CDN $.40 warrants free trading in 7 days....tick tock tick tock
Hmm...the same time the company Pays for a Pump?
Have they Closed the MJ Bio Pharma Deal? You know... the Numbered BC Company that was Incorporated a Few days before being 'ACQUIRED' by VIN?
.
Why does Dr. Will Panenka's wife/Sister/Mom Participate in the Jan 6th offering and get 650k shares, when Will wasn't appointed to the 'SCI BoARD' till the 18th of January?
Probably nothing Shady going on At all...
LOL
GLTFA
I agree. I took profits when it popped.
Will continue to watch and see.
Particularly interested in this next raise and when SP it is at.
he said high yield/low cost....he seems like a good person/straight shooter?
Time will tell
Oh, and as far as VRX developing a drug anytime soon....
$VRX says it paid off $3.6B debt since Q116; if so debt down11%. But EBITDA down 20%+ so lev indicated 7x or worse. https://t.co/gBh3i6fiE1
— Vicki Bryan’s Bond Angle (@VickiBryanBondA) May 1, 2017
$VRX Motions to dismiss the Philidor Class Action (Potter) fail, litigation full steam ahead, court memorandum no bueno for damages pic.twitter.com/zvRLxOmbgy
— luis carruthers (@orthereaboot) May 2, 2017
It's still there. A positive sign IMO
CJ, I took these snapshots from 2015 NMUS presentation
[url=https://ibb.co/jWTFGQ][/url]
[url=https://ibb.co/bQaHVk][/url]
What are your thoughts in terms of NB1111 vs Prosta drugs?
If Prosta drugs are the 'gold standard' as you say, why then does this chart indicate they only have half the market?
What part of the market is still using timolol?
'very company doing raises offers downround protection for a year anyway'
Ahh I didn't know this, thanks.
Thoughts on Cannacords 250k bid?
Eric Adams said on BNN they make cannibinoids the same way Insulin is made...so...probably to FDA standards?
Hey my good friend Vinpat
I have a question for you
I was watching this video about NMUS :
Cannacord just showed up....
CSTI 0.254 250,000 13:20
LOL
bids are larger than usual and no one is selling into them
Day to day is just a mark.
I agree. Part of my thesis on why I am in this sector.
2nd link is broken --> fixed
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553646/
Can you explain about the implants and where NMUS has said this?
'. I also realise there may be neuroprotective effects, but haven't seen any hard data on that.'
This is not true. Look harder.
GLTFA
Very good post, CJ. I like the NMUS board, no pump here. Just real talk. We are all better for it.
Why do you think they used Timolol as a baseline in their studies instead of Latanoprost? It appears what you say is true in terms of Latanoprost > timolol (https://www.ncbi.nlm.nih.gov/pubmed/8628544). That was 1996, so why would they used timolol in studies completed in 2010-2015.
Do they drugs behave differently? Is there anyway to compare the performance of THC-VHS vs Timolol and Latanoprost vs Timolol? Is there the potential for them to be used in conjunction with each other? Do they do different things?
Despite the superiority of Latanoprost as you say, it appears scientists continue to discuss the efficacy of medical marijuana and glaucoma.
--> https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553646/u
If Latanoprost was all you needed to treat the majority of glaucoma cases, why would they continue the debate?
As far as Valeant and Vesneo, GLTFA. I will believe it when I see it.
As far as your concerns about their financial situation, those statements are quite standard for prospectus's. They have no revenues currently and likely for the foreseeable future, so they are required to make those disclosures.
What about the outstanding shares is concerning? The S/O is actually quite low compared to their peers, which is one of the things that makes NMUS attractive.
I look forward to your response and Vinpat's
I do agree that much better people are involved now. Although, the biggest shareholders are still Schneider and Bogart. The SP is still going to get toyed with.
Yes, they are raising it is true. What the raise will be at will be very interesting and will likely determine near team SP. But, raising money with Cannacord is nothing to right home about. Yes, Roth is impressive but Roth is involved all over this space.
We will see, I'm rooting for them and will be watching. I'm wishing good things for everyone in this sector because the more success companies have, the more capital will become available to others (like NMUS).
I don't like being a hater!
No, you just caused me to stop and think.
biosynthesis ---> sounds cool, but lots of competition. There seems to be a lot of companies who can create synthetic cannibinoids (or combos). Like you said, if it really is a disruptive tech with high yield/low cost, why haven't people come knocking?
bioinformatics ---> i feel like all the big boys have similar systems, but dont bother pumping it because they have quality candidates
Drugs --> a long way away and better IP exists out there already (NMUS) and a bunch of cheap warrants flying around
I took profits when it popped, and will wait and see on IMLFF. I make my own choices, dont worry vinpat!
PIPE death spiral financing is always a big risk with micro caps. Just have to hope that the raise will be with people who want to see the company through, and not shove the shares down the markets throat once their hold is up.
Ingram is in for $2.50 a share, says Vinpat. With his own money.
Look up his history with Allergan and $VRX. He doesn't like getting taken out, and especially not buy bad people.
I don't see him taking to kind to a buy out unless it is at a premium to what he paid. although, Lykos and a few others are still the majority holders. I think it is more likely that one of the big boys (ZYNE, GW, INSYS) hit it big, and other banks start looking at the space more serious. More eyes on the sector, and NMUS will be able to get serious funding for their candidates.
Until then, were in survival mode while the company continues to do the little things right.
Capital is not going to be as efficient on the OTC as other markets. Patience will rewards us well with NMUS I think.
Ya, Vinpat has a nice summary of the NMUS long's thesis.
I would add that in addition to not having scammers involved, they have some very quality people with a track record of success.
Now that they fired that simpleton Hollister a few years ago LOL!
To me, the people involved REALLY matter whether you are long or short.
edit: Just wanted to add sceptics are a good thing and I would never bash them. Vinpat's questions on IMLFF made me dig deeper and do some thinking, even though I really loved the story.
Moore's law I guess...
Everything is public
DYODD
I've read that entirely. more than once
WHat pumping are ytou talking about? Not from NMUS people, only straight talk. I think you are confusing NMUS with IMLFF where they pay for pumps and forbes articles
Lots of good talk from my good friend Vinpat, read all his posts on this board ( like I have)
Its on the OTC bro, I think we know its a spec play.
Can you link specifically to the prospectus you are referring to? But...
Look at the people involved in NMUS
Look at how the company has been run
Look at their candidates and IP
This is insanely undervalued compared to peers and Tier 1 cannibinoid companies.
Because of how poorly the RTO went and NMUS stock price, and the fact that it was a RTO, might prevent them from getting the financing they need to get the Phase 1 and 2 trials.
Or, they could get the money, but its Death spiral PiPE and it deludes the Crap out of our holdings.
Were serious Adults here on the NMUS board. I like my side of the bet.
GLTFA
Solar has dropped in price dramatically over the last couple of years. Market has realized this yet. Solar hangover.
UGE pure commercial/industrial play. Market leader in Canada. Rolled up Endura and Carmanah in 12 months. Who cares about utility sized solar when you can get all the power you need from own roof? RIP utility companies.
Very low float.
They have a backlog of contracts that will be executed in 12-18months that is almost 2x their market cap.
CEO is Sweetheart and a good guy.
I bet Jockeys not Horses
GLTFA
LOL Hollister's lawsuit! Does anyone have his initial filings? Seems hilarious...